International Clinical Trial: Expression and Regulatory Mechanisms of SERPING1 and RNASE1 in Peripheral Blood of Patients with Sepsis

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118409) titled 'Expression and Regulatory Mechanisms of SERPING1 and RNASE1 in Peripheral Blood of Patients with Sepsis' on Feb. 5.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: Hangzhou First People's Hospital

Condition: Sepsis

Intervention: Healthy Control Group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-02-15

Target Sample Size: Healthy Control Group:30;Sepsis Patient Group:30;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=308206

Published by HT Digital Content Services with permissio...